I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Andrillon, Anais
21
results:
Search for persons
X
Format
Online (21)
Mediatypes
Articles (Online) (8)
OpenAccess-fulltext (13)
Sorted by: Relevance
Sorted by: Year
?
1
Dose optimization for cancer treatments with considerations..:
Biard, Lucie
;
Andrillon, Anaïs
;
Silva, Rebecca B
.
Clinical Trials. 21 (2024) 3 - p. 322-330 , 2024
Link:
https://doi.org/10.1177/..
?
2
Incorporating patient-reported outcomes in dose-finding cli..:
Andrillon, Anaïs
;
Biard, Lucie
;
Lee, Shing M.
Journal of Biopharmaceutical Statistics. , 2023
Link:
https://doi.org/10.1080/..
?
3
Surv‐CRM‐12: A Bayesian phase I/II survival CRM for right‐c..:
Andrillon, Anaïs
;
Chevret, Sylvie
;
Lee, Shing M.
.
Statistics in Medicine. 41 (2022) 29 - p. 5753-5766 , 2022
Link:
https://doi.org/10.1002/..
?
4
Lower Relapses Rate With Infliximab Versus Adalimumab in Si..:
Maalouf, Georgina
;
Andrillon, Anaïs
;
Leclercq, Mathilde
...
American Journal of Ophthalmology. 238 (2022) - p. 173-180 , 2022
Link:
https://doi.org/10.1016/..
?
5
Mogamulizumab induces long‐term immune restoration and resh..:
Roelens, Marie
;
de Masson, Adèle
;
Andrillon, Anais
...
British Journal of Dermatology. 186 (2022) 6 - p. 1010-1025 , 2022
Link:
https://doi.org/10.1111/..
?
6
Mogamulizumab induces long term immune restoration and resh..:
Roelens, Marie
;
de Masson, Adèle
;
Andrillon, Anais
...
European Journal of Cancer. 156 (2021) - p. S19 , 2021
Link:
https://doi.org/10.1016/..
?
7
Dose-finding design and benchmark for a right censored endp..:
Andrillon, Anaïs
;
Chevret, Sylvie
;
Lee, Shing M
.
Journal of Biopharmaceutical Statistics. 30 (2020) 6 - p. 948-963 , 2020
Link:
https://doi.org/10.1080/..
?
8
Performance of propensity score matching to estimate causal..:
Andrillon, Anais
;
Pirracchio, Romain
;
Chevret, Sylvie
Statistical Methods in Medical Research. 29 (2020) 3 - p. 644-658 , 2020
Link:
https://doi.org/10.1177/..
?
9
Incorporating patient-reported outcomes in dose-finding cli..:
Andrillon, Anaïs
;
Biard, Lucie
;
Lee, Shing M
http://arxiv.org/abs/2303.17705. , 2023
Link:
http://arxiv.org/abs/230..
?
10
Surv‐CRM‐12: A Bayesian phase I/II survival CRM for right‐c..:
Andrillon, Anaïs
;
Chevret, Sylvie
;
Lee, Shing M
.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691552/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
11
Anti-TNF-α versus tocilizumab in the treatment of refractor..:
Leclercq, Mathilde
;
Andrillon, Anaïs
;
Maalouf, Georgina
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ophtha.2021.11.013. , 2021
Link:
https://hal.univ-lorrain..
?
12
Anti-TNF-α versus tocilizumab in the treatment of refractor..:
Leclercq, Mathilde
;
Andrillon, Anaïs
;
Maalouf, Georgina
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ophtha.2021.11.013. , 2021
Link:
https://hal.univ-lorrain..
?
13
Anti-TNF-α versus tocilizumab in the treatment of refractor..:
Leclercq, Mathilde
;
Andrillon, Anaïs
;
Maalouf, Georgina
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ophtha.2021.11.013. , 2021
Link:
https://hal.univ-lorrain..
?
14
Anti-TNF-α versus tocilizumab in the treatment of refractor..:
Leclercq, Mathilde
;
Andrillon, Anaïs
;
Maalouf, Georgina
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ophtha.2021.11.013. , 2021
Link:
https://hal.univ-lorrain..
?
15
Anti-TNF-α versus tocilizumab in the treatment of refractor..:
Leclercq, Mathilde
;
Andrillon, Anaïs
;
Maalouf, Georgina
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ophtha.2021.11.013. , 2021
Link:
https://hal.univ-lorrain..
1-15